Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03498729 · ClinicalTrials.gov registry record
Autoimmunity in the Pathogenesis of AF
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 75
- Enrollment target
NCT03498729: Completed study, sponsored by Mayo Clinic.
NCT03498729 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03498729 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This research study is being done to find out whether autoimmune mechanisms are associated with the development of atrial fibrillation.
Interventions
- OTHER Peripheral Blood Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2021-12-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03498729
The ClinicalTrials.gov registry entry for NCT03498729 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peripheral Blood Sample is the first listed.
NCT03498729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03498729 about?
NCT03498729 is a clinical study titled "Autoimmunity in the Pathogenesis of AF". This research study is being done to find out whether autoimmune mechanisms are associated with the development of atrial fibrillation.
What is the current status of trial NCT03498729?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2018-03-05. Estimated completion is 2021-12-09.
What interventions are being tested in trial NCT03498729?
The interventions under investigation include: Peripheral Blood Sample (OTHER).
Who is sponsoring clinical trial NCT03498729?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.